Research Library
77 citations across the book and 76 unique research sources.
Witches, Midwives and Nurses: A History of Women Healers
Ehrenreich, B. & English, D. The Feminist Press at CUNY 2010. Chapter 1: This history book explains how women were the main healers and herbalists in their communities for centuries, until the rise of male-only formal medicine pushed them out and rebranded their plant knowledge as superstition. Scientific explanation: Historical and sociological text documenting the systematic suppression of lay and folk healers in Western Europe (c. 1400-1700 CE) coinciding with the professionalization of medicine as a male-only enterprise.
Management of Acute Abnormal Uterine Bleeding in Nonpregnant Reproductive-Aged Women
American College of Obstetricians and Gynecologists (ACOG) Obstetrics & Gynecology 2015. Chapter 2: Official medical guidance on how doctors should assess and treat sudden or unusually heavy period bleeding. Scientific explanation: Clinical practice guideline establishing evidence-based protocols for diagnosis and management of non-gestational acute abnormal uterine bleeding.
Premenstrual Syndrome and Premenstrual Dysphoric Disorder: Quality of Life and Burden of Illness
Rapkin, A.J. & Winer, S.A. Expert Review of Pharmacoeconomics & Outcomes Research 2009. Chapter 2: This paper looks at how badly PMS and its more severe form, PMDD, can disrupt a woman's work, relationships, and daily life. Scientific explanation: Health economics and outcomes review quantifying the socioeconomic burden and quality-of-life impairment associated with PMS and PMDD.
The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD)
Halbreich, U. et al. Psychoneuroendocrinology 2003. Chapter 2: A global study measuring how many women experience premenstrual symptoms severe enough to disrupt their daily lives. Scientific explanation: International epidemiological analysis of global prevalence rates and functional impairment associated with PMDD.
The Evaluation and Management of Hirsutism
Azziz, R. Obstetrics & Gynecology (ACOG) 2004. Chapter 2: A clinical reference explaining the brain-to-ovary hormone chain (the HPG axis) that this book uses to explain how the menstrual cycle is controlled. Scientific explanation: Clinical endocrine review used as the textbook reference for hypothalamic-pituitary-gonadal (HPG) axis dynamics.
The Effect of Chamomile on Pain and Menstrual Bleeding in Primary Dysmenorrhea: A Systematic Review
Niazi, A. & Moradi, M. International Journal of Community Based Nursing and Midwifery 2021. Chapter 3: A review pulling together several studies to check whether chamomile really helps with period cramps. It found chamomile does reduce pain. Scientific explanation: Systematic review evaluating chamomile's effect on pain intensity and menstrual blood loss in primary dysmenorrhea.
Chamomile: A herbal medicine of the past with bright future
Srivastava, J.K., Shankar, E. & Gupta, S. Molecular Medicine Reports 2010. Chapter 3: A science review explaining why chamomile works as a gentle muscle relaxer and anti-inflammatory. Scientific explanation: Biochemical review mapping chamomile's active fractions (apigenin, alpha-bisabolol) and their COX-2 inhibition and antispasmodic pathways.
Assessment Report on Matricaria recutita L., flos and Matricaria recutita L., aetheroleum
European Medicines Agency (EMA) EMA Committee on Herbal Medicinal Products 2015. Chapter 3: Europe's official medicine regulator recognizes chamomile as a safe, traditional remedy for cramps, spasms, and bloating. Scientific explanation: Official European regulatory monograph on the safety profile and traditional/well-established use of chamomile flower for gastrointestinal and minor menstrual spasm.
Chamomile tea for relief of primary dysmenorrhea
Jenabi, E. & Ebrahimzadeh, S. Journal of Pediatric and Adolescent Gynecology 2010. Chapter 3: A clinical study where women drank chamomile tea during their periods and reported real drops in pain and anxiety. Scientific explanation: Prospective clinical trial evaluating oral chamomile tea's effect on menstrual pain distress and premenstrual anxiety.
The effect of fennel essential oil on uterine contraction as a model for dysmenorrhea
Ostad, S.N. et al. Journal of Ethnopharmacology 2001. Chapter 3: A lab study showing fennel oil calms the uterine muscle, which is why it may help with cramps. Scientific explanation: Ex vivo bioassay showing fennel essential oil dose-dependently inhibits oxytocin- and prostaglandin-induced uterine tissue contraction.
Efficacy of herbal medicine (cinnamon/fennel/ginger) for primary dysmenorrhea: a systematic review and meta-analysis
Xu, Y. et al. Journal of International Medical Research 2020. Chapter 3, Chapter 10: A large combined analysis showing that cinnamon, fennel, and ginger all genuinely help reduce period pain. Scientific explanation: Meta-analysis pooling RCT data confirming that cinnamon, fennel, and ginger significantly reduce dysmenorrhea pain scores versus placebo.
Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study
Schellenberg, R. BMJ 2001. Chapter 4: A gold-standard human trial where women taking vitex had far fewer PMS symptoms than those on a fake pill. Scientific explanation: Randomized, double-blind, placebo-controlled trial demonstrating standardized Vitex agnus-castus extract significantly reduces PMS symptom severity.
Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review
Cerqueira, R.O. et al. Archives of Women's Mental Health 2017. Chapter 4: A review concluding vitex reliably helps ordinary PMS, though more research is needed for the more severe PMDD. Scientific explanation: Systematic review establishing Vitex as an evidence-supported intervention for PMS, with a noted evidence gap for PMDD specifically.
The treatment of premenstrual syndrome with preparations of Vitex agnus castus: a systematic review and meta-analysis
Marjoribanks, J. et al. American Journal of Obstetrics & Gynecology 2017. Chapter 4, Chapter 10: A combined analysis of many trials confirming that women taking vitex are far more likely to get relief than women taking a sugar pill. Scientific explanation: Meta-analysis confirming Vitex preparations significantly outperform placebo across pooled premenstrual symptom clusters.
Treatment for premenstrual syndrome with Vitex agnus castus: A prospective, randomized, multi-center placebo controlled study in China
He, Z. et al. Maturitas 2009. Chapter 4: A large multi-site study across China confirming vitex reliably reduces severe PMS symptoms. Scientific explanation: Multi-center RCT confirming reproducible efficacy of standardized Vitex extract on premenstrual symptom frequency in a large Chinese cohort.
Treatment of premenstrual syndrome with a phytopharmaceutical formulation containing Vitex agnus castus
Loch, E.G. et al. Journal of Women's Health & Gender-Based Medicine 2000. Chapter 4, Chapter 12: A large real-world study of over 1,600 women using a vitex supplement, most of whom reported their symptoms improved or disappeared. Scientific explanation: Large-scale post-marketing surveillance study (n=1,634) documenting high physician- and patient-reported symptom resolution with standardized Vitex use. Chapter 12: The same large real-world vitex study cited in Chapter 4, referenced again here for its finding that vitex helped normalize irregular cycles. Scientific explanation: Large observational study (n=1,634) documenting normalization of cycle length with standardized Vitex…
A randomized multicenter study of gamolenic acid (Efamast) with and without antioxidant vitamins E and C in benign breast disease
Goyal, A. & Mansel, R.E. Prostaglandins, Leukotrienes and Essential Fatty Acids 2005. Chapter 5: A study showing evening primrose oil's active fat (GLA) can meaningfully ease chronic breast tenderness. Scientific explanation: Randomized multicenter trial showing continuous oral gamolenic acid (GLA) reduces tissue sensitivity and mastalgia severity.
Vitamin E and evening primrose oil for management of cyclical mastalgia: a randomized pilot study
Pruthi, S. et al. Alternative Medicine Review 2010. Chapter 5: A trial comparing vitamin E and evening primrose oil for pre-period breast pain — both helped meaningfully. Scientific explanation: Randomized, double-blind pilot trial showing both EPO and vitamin E produced statistically significant decreases in cyclical mastalgia severity.
Mirghafourvand 2016
Mirghafourvand Mirghafourvand, M., et al. (2016). The effect of evening primrose oil and vitamin E on severity and manifestations of cyclical mastalgia. JMRH. 2016. Chapter 5: A study finding evening primrose oil eases not just breast pain but general body soreness before the period. Scientific explanation: RCT showing GLA supplementation downregulates inflammatory prostaglandin pathways, decreasing peripheral tissue hypersensitivity and premenstrual body discomfort.
A Systematic Review and Meta-Analysis of the Efficacy of Evening Primrose Oil for Mastalgia Treatment
Bilal, I. et al. Nutrients 2021. Chapter 5, Chapter 10: The most rigorous combined analysis to date. Averaged across all women, EPO did not clearly beat a placebo for breast pain overall — an honest negative finding this book reports directly. Scientific explanation: Meta-analysis of 13 RCTs (n=1,752) finding no statistically significant difference between EPO and placebo for mastalgia when cyclical and non-cyclical types are pooled together.
Nutritional and medical importance of gamma-linolenic acid
Horrobin, D.F. Progress in Lipid Research 1992. Chapter 5: A foundational science paper explaining why the body sometimes cannot make enough of the anti-inflammatory fat GLA on its own, especially under stress. Scientific explanation: Seminal biochemical review outlining GLA's conversion to DGLA via the delta-6-desaturase enzyme, and factors that impair that conversion.
Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials
Taku, K. et al. Menopause 2012. Chapter 6: A large analysis proving that soy plant-estrogens meaningfully cut down how often and how badly hot flashes happen. Scientific explanation: Meta-analysis of 17 RCTs finding a statistically significant 20.6% reduction in hot flash frequency and 26.2% reduction in severity with soy isoflavones versus placebo.
Soy food intake and breast cancer survival (Shanghai Breast Cancer Survival Study)
Shu, X.O. et al. JAMA 2009. Chapter 6, Chapter 13: A large study tracking over 5,000 breast cancer survivors found eating soy foods did not raise their cancer risk — if anything, it was linked to better outcomes. Scientific explanation: Prospective cohort study (n=5,042) showing soy food consumption was inversely associated with breast cancer recurrence and mortality in survivors.
Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis
Franco, O.H. et al. JAMA 2016. Chapter 6: A large review of plant-based menopause remedies confirming they genuinely reduce hot flashes. Scientific explanation: Meta-analysis of 62 studies (n=6,653) demonstrating phytoestrogen interventions produce measurable reductions in vasomotor symptom frequency.
Post-diagnosis soy food intake and breast cancer survival: a meta-analysis of cohort studies
Chi, F. et al. Asian Pacific Journal of Cancer Prevention 2013. Chapter 6: Combined data from multiple long-term studies confirms eating soy after a breast cancer diagnosis is safe and may even be protective. Scientific explanation: Meta-analysis of prospective cohorts showing dietary soy isoflavone intake is associated with reduced recurrence and mortality in breast cancer patients.
Combined Red Clover isoflavones and probiotics potently reduce menopausal vasomotor symptoms
Lambert, M.N.T. et al. PLOS ONE 2017. Chapter 6: Pairing red clover with gut-friendly probiotics made the herb work even better at reducing hot flashes. Scientific explanation: Randomized, double-blind, placebo-controlled trial showing probiotic co-administration enhances isoflavone bioavailability and reduces vasomotor symptoms.
Phytoestrogens for vasomotor menopausal symptoms (Cochrane review)
Lethaby, A. et al. Cochrane Database of Systematic Reviews 2007. Chapter 6: A strict Cochrane review found concentrated soy extracts work well, while just adding a little unstandardized soy to the diet gives mixed results. Scientific explanation: Cochrane meta-analysis showing high-genistein botanical extracts yield clear benefit versus placebo, while unstandardized/low-dose dietary soy trials show heterogeneous results.
Soy foods, isoflavones, and the health of postmenopausal women
Messina, M. American Journal of Clinical Nutrition 2014. Chapter 6: A review showing soy doesn't just ease hot flashes — it also helps protect bones and blood vessels without over-stimulating breast tissue. Scientific explanation: Literature review describing soy isoflavones as tissue-selective estrogen receptor modulators, weakly agonistic in bone/vasculature while remaining largely neutral in breast tissue.
Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial (HALT trial)
Newton, K.M. et al. Annals of Internal Medicine 2006. Chapter 7, Chapter 14: The biggest black cohosh study found it didn't beat a placebo — but it used a non-standardized, low-quality preparation, unlike the extracts used in the positive European trials. Scientific explanation: 12-month RCT (n=351) comparing unstandardized black cohosh root powder to placebo, finding no statistical superiority — a result later attributed largely to lack of standardization.
Black cohosh (Cimicifuga spp.) for menopausal symptoms (Cochrane review)
Leach, M.J. & Moore, V. Cochrane Database of Systematic Reviews 2012. Chapter 7: A large safety review of 16 trials found black cohosh doesn't cause reproductive harm, but product quality varies a lot between brands. Scientific explanation: Cochrane review of 16 RCTs (n=2,027) confirming a favorable endometrial safety profile alongside significant manufacturing heterogeneity across trials.
United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity
Mahady, G.B. et al. Menopause 2008. Chapter 7: An official safety review of liver-injury reports found no proven cause-and-effect link between pure black cohosh and liver damage. Scientific explanation: USP Safety Review Committee analysis of case reports concluding causality between black cohosh and hepatotoxicity remains unconfirmed, though biologically plausible.
Ruhlen 2008
Ruhlen Ruhlen, R.L., et al. (2008). Black cohosh does not exert an estrogenic effect on the uterus in postmenopausal women. Maturitas. 2008. Chapter 7: An imaging study confirmed black cohosh does not thicken the uterine lining the way estrogen does, making it a safer option in that respect. Scientific explanation: RCT using transvaginal ultrasound to confirm black cohosh produces no increase in endometrial thickness, supporting a non-estrogenic central mechanism.
Drewe 2013
Drewe Drewe, J., et al. (2013). The role of black cohosh (Actaea/Cimicifuga racemosa) in menopausal therapy reconsidered. Drugs. 2013. Chapter 7, Chapter 13: A re-analysis showing black cohosh works well for hot flashes and mood when you look specifically at the properly standardized European extracts. Scientific explanation: Clinical re-evaluation showing that trials restricted to standardized isopropanolic extracts demonstrate robust efficacy for neurovegetative climacteric complaints.
Saini 2021
Saini Saini, A. & Bhargava, M. (2021). Efficacy and safety of Asparagus racemosus root extract in management of menopausal symptoms: A randomized double-blind placebo controlled trial. Phytomedicine. 2021. Chapter 8, Chapter 11, Chapter 12, Chapter 13: The best human trial on shatavari to date: perimenopausal women taking it had fewer hot flashes, better sleep, and improved vaginal lubrication after 12 weeks. Scientific explanation: 12-week RCT (n=117) showing standardized shatavari extract (5% total saponins) significantly reduced hot flush frequency and improved Greene Climacteric Scale scores versus placebo.
Asparagus racemosus (Shatavari): A versatile female tonic
Sharma, P. et al. International Journal of Pharmaceutical & Biological Archives 2011. Chapter 8: A review mapping out shatavari's chemistry — its antioxidants, immune-supporting compounds, and gentle plant hormones. Scientific explanation: Botanical and pharmacological review cataloging the steroidal saponins (shatavarins I-IV) and cross-lifespan adaptogenic actions of Asparagus racemosus.
Randomized controlled trial of Asparagus racemosus as a galactagogue in lactating women
Kumari, A. et al. Ancient Science of Life 2010. Chapter 8: A trial showing shatavari genuinely helped new mothers who were struggling to produce enough breast milk. Scientific explanation: RCT showing oral shatavari supplementation elevated systemic prolactin levels, correlating with measurable increases in infant weight gain.
Mandal 2000
Mandal Mandal, S.C., et al. (2000). Shatavarin IV, a steroidal saponin from Asparagus racemosus. Phytomedicine. 2000. Chapter 8: A lab study isolating shatavari's key active compound and showing it can calm reproductive muscle spasms. Scientific explanation: Phytochemical isolation study confirming dose-dependent inhibitory effects of Shatavarin IV on spontaneous uterine contractions ex vivo.
Effects of Korean red ginseng on sexual arousal in menopausal women: placebo-controlled double-blind crossover clinical study
Oh, K.J. et al. Journal of Sexual Medicine 2010. Chapter 9: Menopausal women taking Korean red ginseng reported a real boost in sexual arousal and satisfaction compared to a placebo. Scientific explanation: Randomized, double-blind, crossover trial (n=32) showing Korean red ginseng significantly improved Female Sexual Function Index scores.
A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction
Dording, C.M. et al. CNS Neuroscience and Therapeutics 2008. Chapter 9: A trial found high-dose maca root safely helped restore libido lost as a side effect of antidepressant medication. Scientific explanation: Double-blind, randomized, dose-finding study (n=20) showing high-dose maca improved sexual dysfunction scores in SSRI users.
Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Improving Sexual Function in Women: A Pilot Study
Dongre, S. et al. BioMed Research International 2015. Chapter 9, Chapter 11: Women with stress-related low libido saw meaningful improvement across every measure of sexual function after taking ashwagandha for eight weeks. Scientific explanation: Randomized, double-blind, placebo-controlled study (n=50) showing standardized KSM-66 ashwagandha significantly improved all six FSFI domains, via cortisol reduction.
Ginkgo biloba for antidepressant-induced sexual dysfunction
Cohen, A.J. & Bartlik, B. Journal of Sex & Marital Therapy 1998. Chapter 9: An early study found ginkgo helped restore libido blunted by antidepressant medication, likely by improving blood flow. Scientific explanation: Open-label trial reporting improvement in medication-induced sexual dysfunction with Ginkgo biloba extract (EGb 761), attributed to nitric oxide-mediated vasodilation.
Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials
Ernst, E. & Pittler, M.H. Journal of Urology 1998. Chapter 9: Confirms yohimbine genuinely improves blood flow to pelvic tissue, but this is a fast-acting, medically supervised compound, not a casual home remedy. Scientific explanation: Systematic review and meta-analysis confirming yohimbine's efficacy over placebo, acting as a selective alpha-2 adrenergic antagonist producing smooth muscle vasodilation.
A placebo-controlled, double-blind trial of Ginkgo biloba for antidepressant-induced sexual dysfunction
Kang, B.J. et al. Human Psychopharmacology 2004. Chapter 9: A stricter follow-up study found ginkgo alone did not beat a placebo — a reminder that earlier positive results need replication. Scientific explanation: 12-week, randomized, double-blind, placebo-controlled trial finding no statistically significant difference between ginkgo and placebo for antidepressant-induced sexual dysfunction.
The effect of cinnamon on primary dysmenorrhea: a randomized, double-blind clinical trial
Jahangirifar, M. et al. Complementary Therapies in Clinical Practice 2018. Chapter 10: A clinical trial found cinnamon capsules meaningfully reduced period pain over two cycles. Scientific explanation: Randomized, double-blind, placebo-controlled trial (n=80) showing 3g/day cinnamon produced statistically significant pain reduction versus placebo across two menstrual cycles.
Epidemiology of Endometriosis, a Systematic Review and Meta-Analysis
Direkvand-Moghadam, A. et al. Journal of Research in Medical Sciences 2014. Chapter 10: A worldwide review showing endometriosis is far more common than most women realize, especially among those with chronic pelvic pain. Scientific explanation: Meta-analysis establishing global endometriosis prevalence at 5-10% of reproductive-age women, rising to 35-50% among those with chronic pelvic pain or infertility.
Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinaemia (RCT)
Milewicz, A. et al. Arzneimittelforschung 1993. Chapter 11: A trial showing vitex lowers a stress-linked hormone (prolactin) enough to correct a short, weak second half of the cycle that can make conceiving harder. Scientific explanation: Randomized, double-blind, placebo-controlled trial (n=52) showing Vitex normalized elevated prolactin and corrected shortened luteal phases in women with latent hyperprolactinaemia.
Herbal medicine for the management of polycystic ovary syndrome and associated oligo/amenorrhoea and selected comorbidities: a systematic review
Arentz, S. et al. BMC Complementary and Alternative Medicine 2014. Chapter 11: A review finding that certain herbs, including vitex, can help bring back more regular periods and ovulation in women with PCOS. Scientific explanation: Systematic review identifying Vitex agnus-castus among herbs with the most consistent evidence for improving cycle regularity in PCOS-associated oligo/amenorrhoea.
Raspberry leaf in pregnancy: its safety and efficacy in labor (RCT)
Simpson, M. et al. Journal of Midwifery and Women's Health 2001. Chapter 11: A trial found that women drinking raspberry leaf tea late in pregnancy had a shorter second stage of labor with no added risk. Scientific explanation: RCT (n=192) showing raspberry leaf tablets from 32 weeks gestation reduced the duration of the second stage of labor without adverse events.
Perceived stress and fecundability: a prospective cohort study of pregnancy planners
Wesselink, A.K. et al. Human Reproduction 2018. Chapter 11: A study tracking thousands of women trying to conceive found high stress was linked to a meaningfully lower chance of getting pregnant each cycle. Scientific explanation: Prospective cohort study (n=4,769) finding high perceived stress independently associated with a 45% increased risk of infertility.
Preconception stress increases the risk of infertility: results from a couple-based prospective cohort study (LIFE study)
Lynch, C.D. et al. Human Reproduction 2014. Chapter 11: Testing saliva for stress chemicals, researchers found women with the highest stress markers had more than double the risk of infertility. Scientific explanation: Prospective cohort study measuring urinary/salivary alpha-amylase, finding women in the highest sympathetic-activation tier had more than double the cycle-specific infertility rate.
Real-world menstrual cycle characteristics of more than 600,000 menstrual cycles
Bull, J.R. et al. npj Digital Medicine 2019. Chapter 11: A massive tracking-app study proving that a 'textbook' 28-day cycle is actually uncommon — healthy cycles vary widely. Scientific explanation: Large-scale digital database analysis (n=612,578 cycles) showing combined BBT and LH-surge tracking accurately identifies the fertile window, outperforming calendar-only methods.
Executive summary of the Stages of Reproductive Aging Workshop +10 (STRAW+10)
Harlow, S.D. et al. Menopause & Fertility and Sterility 2012. Chapter 12: The official expert framework doctors use to define and stage the years of perimenopause based on cycle changes. Scientific explanation: Consensus staging system (STRAW+10) defining the menopausal transition based on persistent cycle-length variability and time since the final menstrual period.
Characterization of reproductive hormonal dynamics in the perimenopause (SWAN analysis)
Santoro, N. et al. Journal of Clinical Endocrinology and Metabolism 2003. Chapter 12: A long-term study showing perimenopause hormones don't fall gently — they swing unpredictably, sometimes high, sometimes low, for up to a decade. Scientific explanation: Longitudinal SWAN analysis documenting declining progesterone metabolites and increasing anovulatory cycles years before the final menstrual period.
Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition (SWAN publication)
Kravitz, H.M. et al. Menopause 2005. Chapter 12: A large community survey found insomnia becomes far more common as women move through the menopause transition. Scientific explanation: Longitudinal SWAN survey (n=3,261) showing insomnia prevalence rises substantially from premenopause through late perimenopause.
Sleep problems in midlife and beyond: two distinct mechanisms, vasomotor and progesterone-withdrawal
Polo-Kantola, P. Maturitas 2011. Chapter 12: Explains that midlife sleep trouble has two separate causes: hot-flush-driven waking, and the loss of progesterone's natural calming effect on the brain. Scientific explanation: Endocrine review distinguishing autonomic vasomotor sleep disruption from GABA-A-mediated sleep disruption driven by progesterone/allopregnanolone withdrawal.
Valerian for sleep: a systematic review and meta-analysis
Bent, S. et al. American Journal of Medicine 2006. Chapter 12: A combined analysis found valerian root can genuinely improve sleep quality without the risks of prescription sleep drugs. Scientific explanation: Systematic review and meta-analysis of 16 RCTs concluding valerian may improve sleep quality without significant adverse effects, though evidence was not definitive.
Effect of valerian on sleep quality in postmenopausal women: a randomized placebo-controlled clinical trial
Taavoni, S. et al. Menopause 2011. Chapter 12: A trial of postmenopausal women with poor sleep found valerian root produced a real, measurable improvement over four weeks. Scientific explanation: RCT (n=100) showing valerian root extract (530mg twice daily) significantly improved Pittsburgh Sleep Quality Index scores versus placebo.
Valerian/lemon balm use for sleep disorders during menopause
Taavoni, S. et al. Complementary Therapies in Clinical Practice 2013. Chapter 12: Combining valerian with lemon balm worked even better together than valerian alone for menopausal sleep problems. Scientific explanation: RCT (n=100) showing valerian plus lemon balm significantly improved sleep disturbance scores, via complementary GABA-enhancing mechanisms.
GABA A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts
Benke, D. et al. European Journal of Pharmacology 2009. Chapter 12: A lab study pinpointing exactly how valerian's active compound calms the brain — by acting on the same receptors as anti-anxiety medication. Scientific explanation: Molecular pharmacology study confirming valerenic acid acts as a positive allosteric modulator of GABA-A receptors, without directly activating the receptor.
Valerenic acid potentiates and inhibits GABA(A) receptors: molecular mechanism and subunit specificity
Khom, S. et al. Neuropharmacology 2007. Chapter 12: A detailed brain-chemistry study confirming valerian's compound selectively boosts the brain's own calming signals. Scientific explanation: Electrophysiological study demonstrating valerenic acid's subunit-specific potentiation of GABA-A receptor chloride currents.
St John's wort for major depression (Cochrane systematic review, 29 RCTs, n>5,000)
Linde, K. et al. Cochrane Database of Systematic Reviews 2008. Chapter 12: A major review of over 5,000 patients found high-quality St. John's Wort extract works about as well as standard antidepressants for mild depression, with fewer side effects. Scientific explanation: Cochrane meta-analysis of 29 RCTs (n>5,000) showing standardized Hypericum extracts are superior to placebo and comparable to SSRIs for mild-to-moderate depression.
St. John's Wort extract: efficacy for menopausal symptoms of psychological origin [open-label, n=111 perimenopausal women]
Grube, B. et al. Advances in Therapy 1999. Chapter 12: An open study found St. John's Wort meaningfully lifted mood and eased physical menopause symptoms in perimenopausal women over 12 weeks. Scientific explanation: Open-label trial (n=111) showing standardized Hypericum extract (900mg/day) produced significant improvement in psychological and psychosomatic perimenopausal symptoms.
Black cohosh and St. John's wort for climacteric complaints: a randomized trial [n=301, 16 weeks, RCT]
Uebelhack, R. et al. Obstetrics and Gynecology 2006. Chapter 12, Chapter 13: A strong trial found that combining black cohosh with St. John's Wort worked much better than a placebo at easing hot flashes, anxiety, and low mood together. Scientific explanation: Double-blind RCT (n=301) showing the fixed combination of isopropanolic black cohosh and ethanolic St. John's Wort extracts produced significantly greater reduction in Menopause Rating Scale and Hamilton Depression scores than placebo.
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial
Rossouw, J.E. et al. (WHI Investigators) JAMA 2002. Chapter 13: The famous 2002 study that found a small increased risk of breast cancer and heart disease with HRT — the trial that caused millions of women to stop hormone therapy. Scientific explanation: RCT (n=16,608, mean age 63) reporting increased risk of breast cancer, coronary heart disease, stroke, and blood clots with combined estrogen-progestin therapy; absolute risk increase of 8 additional breast cancer cases per 10,000 women per year.
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials
Manson, J.E. et al. JAMA 2013. Chapter 13: A follow-up re-analysis found that HRT's risk depends heavily on age: starting it close to menopause is much safer than starting it a decade or more later. Scientific explanation: Major WHI reanalysis establishing the 'timing hypothesis' — a more favorable cardiovascular and overall risk profile for women initiating HRT within 10 years of menopause onset or before age 60.
The 2022 hormone therapy position statement of The Menopause Society
The NAMS 2022 Hormone Therapy Position Statement Advisory Panel Menopause 2022. Chapter 13: The current official medical guidance stating that for most healthy women under 60, or within 10 years of menopause, the benefits of HRT outweigh the risks. Scientific explanation: Consensus clinical guideline defining the favorable benefit-risk ratio of hormone therapy for vasomotor symptoms and bone loss prevention in appropriate candidates.
Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms
Liu, J. et al. Journal of Agricultural and Food Chemistry 2001. Chapter 13: A lab study screening plant extracts for estrogen-like activity, supporting the receptor-binding science behind menopausal herbs. Scientific explanation: Laboratory screening study assessing relative estrogen receptor binding activity across a panel of botanical extracts used for menopausal symptom relief.
The effect of menopause on the skin and other connective tissues
Calleja-Agius, J. & Brincat, M. Gynecological Endocrinology 2012. Chapter 13: A review explaining why skin gets thinner and drier after menopause, and how much of that is directly caused by falling estrogen. Scientific explanation: Review detailing estrogen receptor-mediated regulation of dermal collagen synthesis and connective tissue integrity across the menopausal transition.
Systemic evening primrose oil improves the biophysical skin parameters of healthy adults
Muggli, R. International Journal of Cosmetic Science 2005. Chapter 13: A controlled trial found that taking evening primrose oil as a supplement measurably improved skin moisture and elasticity from the inside out. Scientific explanation: Placebo-controlled trial documenting measurable improvements in transepidermal water loss and skin elasticity with GLA supplementation over 10-12 weeks.
Ginkgo biloba for cognitive impairment and dementia (Cochrane review)
Birks, J. & Grimley Evans, J. Cochrane Database of Systematic Reviews 2009. Chapter 13: A large review found ginkgo doesn't prevent dementia, but it does modestly improve day-to-day thinking and focus in people without dementia. Scientific explanation: Cochrane review of 36 RCTs (n>4,000) finding no convincing evidence ginkgo prevents dementia, but consistent modest cognitive improvement in non-demented individuals using EGb 761-standardized preparations.
Supplement quality: navigating a complex landscape
Cooperman, T. & Cooperman, W. Journal of the Academy of Nutrition and Dietetics 2016. Chapter 14: An overview of how independent testing groups check whether supplement bottles actually contain what the label says. Scientific explanation: Review describing the methodology and role of independent supplement quality certification bodies (ConsumerLab, NSF, USP) in verifying label accuracy.
Analysis of select dietary supplement products marketed to support or boost the immune system
Crawford, C. et al. JAMA Network Open 2022. Chapter 14: Lab testing of 30 popular online immune supplements found more than half had inaccurate labels — some didn't contain what they claimed at all. Scientific explanation: Case series analysis (n=30 Amazon-purchased supplements) using LC-MS testing, finding 17 products had inaccurate labels, 13 misbranded and 9 containing undisclosed ingredients.
Efficacy of black cohosh-containing preparations on menopausal symptoms: a meta-analysis
Shams, T. et al. Alternative Therapies in Health and Medicine 2010. Chapter 14: A combined analysis of nine trials found black cohosh improves hot flushes by about a quarter on average, though results varied by preparation type. Scientific explanation: Meta-analysis of 9 placebo-controlled RCTs finding black cohosh preparations improved menopausal vasomotor symptoms by 26% overall, with heterogeneity attributed to differing preparation types.
Interactions between herbal medicines and prescribed drugs: a systematic review
Izzo, A.A. & Ernst, E. Drugs 2001. Chapter 14: A foundational safety review identifying St. John's Wort as the herb most likely to interfere with prescription medications. Scientific explanation: Systematic review identifying St. John's Wort as the herb with the most clinically documented pharmacokinetic interactions, primarily via CYP3A4 and P-glycoprotein induction.
Interaction of herbal products with prescribed medicines: A systematic review and meta-analysis
Awortwe, C., Bruckmueller, H. & Cascorbi, I. Pharmacological Research 2019. Chapter 14: An updated review of 32 studies confirmed St. John's Wort still causes the most significant drug-level drops among commonly used herbs. Scientific explanation: Systematic review and meta-analysis of 32 pharmacokinetic/pharmacodynamic herb-drug interaction studies, confirming St. John's Wort produces the most significant reduction in co-administered drug levels.
Analysis of drug interactions involving ginkgo biloba extract (EGb) in hospital prescriptions: a retrospective observational study
Mai, H.T. et al. PLOS ONE 2025. Chapter 14: A hospital records review found ginkgo was involved in real, documented interactions with blood-thinning medications in nearly 13% of relevant prescriptions. Scientific explanation: Retrospective observational study of 2,647 hospital prescriptions finding 12.94% exhibited drug interactions involving ginkgo biloba extract, most commonly with clopidogrel and aspirin.